The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer ; volume:9 ; number:1 ; day:17 ; month:8 ; year:2018 ; pages:1-12 ; date:12.2018
Nature Communications ; 9, Heft 1 (17.8.2018), 1-12, 12.2018
- Urheber
-
Ma, Jennifer
- Beteiligte Personen und Organisationen
-
Setton, Jeremy
Lee, Nancy Y.
Riaz, Nadeem
Powell, Simon N.
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-05228-y
- URN
-
urn:nbn:de:101:1-2018102714192606520647
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Jennifer
- Setton, Jeremy
- Lee, Nancy Y.
- Riaz, Nadeem
- Powell, Simon N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
DNA nicks induce mutational signatures associated with BRCA1 deficiency
Mutational signatures are jointly shaped by DNA damage and repair
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
Mutational signatures in colon cancer
Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers
Mutational signatures of genotoxic cancer therapies
Mutational signatures: experimental design and analytical framework
Signatures of mutational processes in human cancer
Mutational signatures among young-onset testicular cancers
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples
SigsPack, a package for cancer mutational signatures
DNA nicks induce mutational signatures associated with BRCA1 deficiency
Mutational signatures are jointly shaped by DNA damage and repair
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
Mutational signatures in colon cancer
Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers
Mutational signatures of genotoxic cancer therapies
Mutational signatures: experimental design and analytical framework
Signatures of mutational processes in human cancer
Mutational signatures among young-onset testicular cancers
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples
SigsPack, a package for cancer mutational signatures
DNA nicks induce mutational signatures associated with BRCA1 deficiency
Mutational signatures are jointly shaped by DNA damage and repair
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
Mutational signatures in colon cancer
Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers
Mutational signatures of genotoxic cancer therapies
Mutational signatures: experimental design and analytical framework
Signatures of mutational processes in human cancer
Mutational signatures among young-onset testicular cancers
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples